A multi‑stаte heаlth cаre cоmpany (“HealthCо”) is оwned and controlled by a private equity fund. employs physicians and advanced practice providers to deliver outpatient services through a network of clinics. To increase efficiency and profitability, HealthCo recently implemented an artificial intelligence–driven clinical decision-support system (“AI Tool”) that assists with diagnosis, treatment recommendations, and patient triage. After rollout of the AI Tool at the clinic, several adverse patient outcomes occur. In one case, a physician follows the AI Tool’s recommendation, which later proves inconsistent with prevailing clinical standards. In another case, a physician overrides the AI Tool, resulting in administrative discipline and termination for “noncompliance with company protocols.” Patients file malpractice suits against the physicians, HealthCo, and the AI vendor. What are the major legal and regulatory issues raised in this case?
A 60-yeаr-оld pаtient tаking ciprоflоxacin (Cipro) develops tendon pain and inflammation. Which of the following is the most appropriate next step?